74
Participants
Start Date
July 31, 2009
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
KNS-760704
150 mg Q12H KNS-760704 given orally (300 mg total daily dose)
Columbia University, Lou Gehrig MDA/ALS Research Center, New York
SUNY Upstate Medical University, Syracuse
University of Pittsburgh School of Medicine, Pittsburgh
Penn State Hershey Medical Center, Hershey
Drexel University College Of Medicine, Philadelphia
Johns Hopkins University School of Medicine, Baltimore
University of Virginia Health System, Charlottesville
University of Miami Miller School of Medicine, Miami
Vanderbilt University Medical Center, Nashville
Washington University School of Medicine, St Louis
University of Kansas Medical Center, Kansas City
Bryan LGH Medical Center East, Lincoln
University of Arkansas for Medical Sciences, Little Rock
University of Texas Health Sciences Center of San Antonio, San Antonio
University of Utah, Salt Lake City
UCLA, Dept. of Neurology - Neuromuscular/ALS Research Center, Los Angeles
The Forbes Norris MDA/ALS Research Center, San Francisco
University of Washington, Seattle
Massachusettes General Hospital, Boston
Lead Sponsor
Knopp Biosciences
INDUSTRY